Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

EKSO - Ekso Bionics Holdings Inc


IEX Last Trade
1.23
0.110   8.943%

Share volume: 383,098
Last Updated: Fri 30 Aug 2024 09:59:34 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$1.12
0.11
9.82%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
36%
Profitability 50%
Dept financing 25%
Liquidity 37%
Performance 25%
Company vs Stock growth
vs
Performance
5 Days
12.15%
1 Month
13.21%
3 Months
1.69%
6 Months
-39.09%
1 Year
27.92%
2 Year
-49.79%
Key data
Stock price
$1.23
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.62 - $3.13
52 WEEK CHANGE
$0.33
MARKET CAP 
22.133 M
YIELD 
N/A
SHARES OUTSTANDING 
18.444 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
0.46
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$148,388
AVERAGE 30 VOLUME 
$103,362
Company detail
CEO: Jack Peurach
Region: US
Website: https://ir.eksobionics.com/
Employees: 116
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

since 2005, ekso bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. the company’s first commercially available product called ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. by designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, ekso bionics is helping people rethink current physical limitations and achieve the remarkable. ekso bionics is headquartered in richmond, california international offices: europe/middle east/africa 29th floor one canada square canary wharf london, united kingdom +44 20 7060 3568 kunden service deutschland +49 89 55067774

Recent news